Results 71 to 80 of about 40,507 (289)

Does Allowing Track 2 MAiD Harm Disabled People?

open access: yesCanadian Journal of Bioethics
In 2021, in response to the Superior Court of Quebec’s decision in Truchon v. Canada, the Canadian Parliament amended the Criminal Code to allow Medical Assistance in Dying (MAiD) for some people who don’t have a “reasonably foreseeable natural death ...
Nicholas Abernethy
doaj   +1 more source

The Moderate Approach to Advance Requests for Medical Assistance in Dying in Advanced Dementia

open access: yes, 2022
The purpose of this thesis is to provide an approach to advance requests for MAiD in the setting of advanced dementia. Development of such an approach will require facing important ethical questions and metaphysical challenges.
Holland, Timothy
core  

From mice to humans—divergent strategies for intestinal homeostasis and regeneration

open access: yesFEBS Letters, EarlyView.
Recent advances such as organoid genome editing, xenotransplantation, imaging, and whole‐genome sequencing have enabled direct studies of human intestinal stem cells (ISCs). These studies reveal species‐specific features, including slower ISC proliferation, distinct injury responses, slower somatic mutation accumulation in humans, and an inverse ...
Keiko Ishikawa   +2 more
wiley   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

Semantics in referring for medical assistance in dying [PDF]

open access: yesCanadian Medical Association Journal, 2018
The title “Doctors do not need to refer for medical assistance in dying” for the editorial[1][1] in the emailed list of contents for the February 20, 2018, issue is misleading. Physicians, at least in Ontario, do need to refer for medical assistance in dying (MAiD), so, as the article notes,
openaire   +2 more sources

Medical Assistance in Dying and Disability Rights

open access: yes, 2021
Disability rights activists have raised strong criticisms regarding the liberalization of Medical Assistance in Dying (MAID) as a dehumanizing practice of those whose lives are deemed less valuable by a prejudiced society.
Marquardt, Daniel Stephen
core  

Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment

open access: yesMolecular Oncology, EarlyView.
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley   +1 more source

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression

open access: yesMolecular Oncology, EarlyView.
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge   +17 more
wiley   +1 more source

Ethical arguments against coercing provider participation in MAiD (medical assistance in dying) in Ontario, Canada

open access: yesBMC Medical Ethics, 2020
It has historically been a crime in Canada to provide assistance to someone in ending their own life, however, this paradigm was inverted in 2015 when the Supreme Court of Canada (SCC) ruled that restrictions on this practice, within certain defined ...
Travis Carpenter, Lucas Vivas
doaj   +1 more source

EDNRB‐dependent endothelin signaling reduces proliferation and promotes proneural‐to‐mesenchymal transition in gliomas

open access: yesMolecular Oncology, EarlyView.
Glioma cells mainly express the endothelin receptor EDNRB, while EDNRA is restricted to a perivascular tumor subpopulation. Endothelin signaling reduces glioma cell proliferation while promoting migration and a proneural‐to‐mesenchymal transition associated with poor prognosis. This pathway activates Ca2+, K+, ERK, and STAT3 signalings and is regulated
Donovan Pineau   +36 more
wiley   +1 more source

Home - About - Disclaimer - Privacy